ArticleBMC microbiology2026
Molecular detection of extended-spectrum β-Lactamase genes in multi-drug-resistant bacteria isolated from drinking water supply and surface water systems in Addis Ababa, Ethiopia.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe emergence of β-lactamase-producing bacteria is a critical global public health threat that undermines the efficacy of last-resort antibiotics. In Ethiopia, studies exploring resistance genes in drinking water systems are scarce. This study investigated bacterial profiles, antimicrobial susceptibility, and associated Extended-Spectrum β-Lactamase (ESBL) genes, including blaTEM, blaCTXM and blaSHV.
methodsA cross-sectional study was conducted between March 2023 and April 2024 by sampling raw, finished, reservoir, tap, and storage tank water in Addis Ababa. The samples were processed aseptically with routine microbiological culture and characterization methods. Antibiotic susceptibility testing was conducted using standardized Kirby-Bauer disc diffusion method as described by Clinical Laboratory Standards Institute (CLSI) version 33 guidelines. All data recorded were validated and then analyzed by Statistical Package for the Social Sciences version 25.0 Armonk. The associated parameters were compared using Fishers' exact test to determine their correlation. In all cases, a p-value less than or equal to 0.05 was considered statistically significant.
resultsFrom 45 samples, 94 bacterial species were characterized. Dominant isolates included E. coli (23.4%), Enterobacter spp. (16%), Citrobacter spp. (10.6%), K. pneumoniae (10.6%), Proteus spp. (8.5%), and Coagulase negative Staphylococcus species. Multi-drug resistant (MDR) is a non-susceptibility of an isolate to at least one antibiotic agent in three or more antimicrobial classes. Disc diffusion tests revealed that 63.8% (60/94) of isolates were MDR. The highest resistance levels were observed for ampicillin (86%), tetracycline (72.7%), cefuroxime (66.2%), and cefoxitin (53.5%). The principal MDR isolates were E. coli, Enterobacter, and Klebsiella species. Multiplex PCR on genomic DNA of MDR isolates showed a 26.6% (16/60) occurrence of ESBL genes; the combination of blaCTXM + blaTEM 11.7% (7/60) being the most frequent, followed by blaTEM (10%), blaCTXM (3.3%), and blaSHV (1.7%). In plasmid DNA of Gram-negative MDR isolates, ESBL genes occurred in 10.9% (6/54), with blaTEM (7.3%) being dominant, followed by blaCTXM (0.18%) and co-occurring blaSHV + blaTEM (0.18%).
conclusionThis study confirms the presence of ESBL genes in both the genomic and plasmid DNA of MDR bacteria in the water supply, particularly in storage tanks, tap and raw water. These findings indicate the transmission of β-lactamase-producing bacteria into drinking water supply systems. Regular monitoring, surveillance, and rigorous studies to identify contamination sources and mitigation strategies are urgently recommended.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.